LIPOCINE INC. Stock Issued During Period, Value, Stock Dividend
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIPOCINE INC. stock issued during period, value, stock dividend for the quarter ending 2023-12-31 was $89.00.
- LIPOCINE INC. stock issued during period, value, stock dividend for fiscal 2023 was $80.00.
| Period end | Stock Issued During Period, Value, Stock Dividend 3 month | Stock Issued During Period, Value, Stock Dividend 12 month |
|---|---|---|
| 2023-12-31 | $89.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $80.00 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |